Financials

  • Market Capitalization 996.54 M
  • Employee 21
  • Founded 2012
  • CEO N/A
  • Website www.immixbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00HLCWH09
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2451
CADL
Candel Therapeutics, Inc. - Common Stock
13.25 USD-3.64%+2.32%+35.07%+126.50%1.01 B USD
2454
ABUS
Arbutus Biopharma Corporation - Common Stock
5.10 USD-1.35%-0.58%+15.65%+38.59%1.01 B USD
2466
GERN
Geron Corporation - Common Stock
1.51 USD-1.31%-3.82%+4.86%+4.86%970.13 M USD
2488
ANNX
Annexon, Inc. - common stock
5.02 USD-4.38%-2.52%+1.01%+136.79%951.69 M USD

Notizie